Total Medical devices industry venture financing deals worth $4.5bn were announced globally in Q2 2022, led by $300m venture financing of Biofourmis, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 37.7% over the previous quarter and a drop of 42.2% when compared with the last four-quarter average, which stood at $7.73bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals worth $2.66bn in the period. At the country level, the US topped the list in terms of deal value at $2.63bn.

In terms of volumes, North America emerged as the top region for Medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top country in terms of venture financing deals activity in Q2 2022 was the US with 185 deals, followed by China with 79 and the UK with 11.

In 2022, at the end of , venture financing deals worth $4.5bn were announced globally in Medical devices industry, marking a decrease of 18.6% year on year.

venture financing deals in Medical devices industry in Q2 2022: Top deals

The top five venture financing deals in Medical devices industry accounted for 19.7% of the overall value during Q2 2022.

The combined value of the top five venture financing deals stood at $880m, against the overall value of $4.5bn recorded for the quarter.

The top five Medical devices industry venture financing deals of Q2 2022 tracked by GlobalData were:

1) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis

2) The $220m venture financing of Reify Health by Adams Street Partners,Altimeter Capital Management,Battery Ventures,Coatue,Dragoneer Investment Group and ICONIQ Growth

3) Impact Investment Partners,Japan Industrial Partners and NEC $150m venture financing deal with BostonGene

4) The $110m venture financing of Aidoc Medical by Alpha Intelligence Capital,CDIB Capital and TCMI

5) Charles River Ventures,GV Management Co,Insight Partners,Kleiner Perkins,Scale Ventures,Sozo Ventures,Susa Ventures,Threshold Ventures and Tiger Global Management $100m venture financing deal with Viz.ai